Related Experiment Video
Updated: Aug 14, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
Tumor necrosis factor alpha and interleukin 6 in infants with sepsis
Praveen Makhija1, Sangita Yadav, Archana Thakur
1Department of Pediatrics, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi 110 002, India.
Insights
Elevated tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) indicate infant sepsis. TNF-alpha decrease suggests survival, while IL-6 increase correlates with severe sepsis and mortality in infants.
Area of Science:
- Pediatrics
- Immunology
- Infectious Diseases
Background:
- Neonatal sepsis is a leading cause of infant mortality.
- Early diagnosis and prognostic markers are crucial for improving outcomes.
- Cytokines like TNF-alpha and IL-6 are key inflammatory mediators in sepsis.
Purpose of the Study:
- To investigate the role of tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) in infant sepsis.
- To examine the relationship between initial and changing cytokine levels and patient outcomes.
Main Methods:
- Prospective study of 32 infants with suspected sepsis.
- Measurement of serum TNF-alpha and IL-6 levels at admission and 48-72 hours.
- Correlation of cytokine levels with clinical outcomes (sepsis, septic shock, survival).
Main Results:
- Infants with sepsis exhibited significantly higher TNF-alpha and IL-6 levels than controls.
- Decreased TNF-alpha levels were observed in sepsis, septic shock, and survivors.
- Non-survivors showed no significant change in TNF-alpha.
- Higher initial IL-6 levels were noted in septic shock and non-survivors.
- IL-6 levels increased in sepsis, septic shock, and non-survivors at 48 hours.
Conclusions:
- TNF-alpha and IL-6 are valuable biomarkers for infant sepsis diagnosis and prognosis.
- Changes in TNF-alpha levels may predict survival in infants with sepsis.
- Elevated and increasing IL-6 levels are associated with severe sepsis and mortality.
Abstract:
Thirty-two infants above one month of age admitted to a tertiary care hospital with signs of infection and presumptive diagnosis of sepsis were included. Cytokine levels of tumor necrosis factor alpha (TNFmu) and interleukin-6 (IL 6) were estimated at admission and after 48 to 72 hr, and their relationship examined to the outcome. Significantly higher TNFalpha and IL-6 levels were seen in infants with sepsis compared to control. The TNFalpha levels significantly decreased in patients with sepsis, septic shock and the survivors, while the patients who did not survive, the levels showed no significant change after 48 hr. The initial levels of IL6 were comparatively higher in patients with septic shock and non-survivors, and increased at 48 hr of admission in patients with sepsis, septic shock and non-survivors.
Related Concept Videos
Acute Inflammation III: Local and Systemic Effects
Bacterial Meningitis II: Pathophysiology

